[20200415]IN11337_《国防生产法》（DPA）和2019冠状病毒疾病大流行：最近的事态发展和政策考虑.pdf

CRS INSIGHT Prepared for Members and Committees of Congress INSIGHTINSIGHTi i The Defense Production Act (DPA) and the COVID-19 Pandemic: Recent Developments and Policy Considerations Michael H. Cecire Analyst in Intergovernmental Relations and Economic Development Policy Heidi M. Peters Analyst in U.S. Defense Acquisition Policy April 15, 2020 In response to the COVID-19 pandemic, the Administration invoked the Defense Production Act of 1950 (DPA) on multiple occasions to facilitate the manufacture and distribution of medical equipment and supplies. The full extent of DPA implementation is unclearto date, there have been six public announcements describing official DPA implementation actions. This Insight describes recent DPA actions and reported implementation with regard to the COVID-19 pandemic, and discusses policy considerations for Congress. It is intended as a companion to CRS Insights IN11280 and IN11231. See CRS Report R43767 for a more in-depth discussion of DPA history and authorities. For additional related resources, see the CRS Coronavirus Disease 2019 homepage. Recent DPA Actions As of April 15, the Administration has issued three DPA-related executive orders and fo